Leadership must keep pace to evolve and stay competitive.
CGTI.ai brings together global cell and gene therapy leaders to clear CGT manufacturing bottlenecks with AI‑enabled bioprocessing, agile capacity and sustainable, resilient operations.
01 · CGTI.ai
CGT Innovation Leaders Dialogue London 2026
The four pillars of CGTI.ai
AI‑enabled bioprocessing
Why it matters: It makes AI a trusted co‑pilot for complex CGT batches – stabilising autologous and allogeneic processes, cutting batch failure, and speeding right‑first‑time release from vein to vein.
Agile capacity and networks
Why it matters: It lets CGT leaders design modular, distributed networks – from in‑house suites to specialist CDMOs – that can follow patients and indications without breaking comparability.
Workforce and human systems
Why it matters: It protects scarce CGT talent, turning operators, MSAT and QA into AI‑literate decision‑makers who can trust, challenge and improve digital twins and algorithms on the shop floor.
Sustainable resilient operations
Why it matters: It hard‑wires resilience into CGT – from starting‑material security to cold‑chain and chain‑of‑identity – so therapies stay available, affordable and inspection‑ready as volumes grow.
02 · THE GAP
Curated for senior ops & manufacturing leaders
Why it Matters.
In 2026, AI, automation and digital bioprocessing are moving from pilots into the heart of cell and gene therapy manufacturing.
At the same time, companies are committing record capital to new CGT facilities and regional networks while facing tight margins, skills gaps and rising sustainability expectations.
The question is no longer whether these shifts are coming, but how to deploy them in CGT without breaking cost, compliance or supply.
Cell Biology at Scale.
Three Industries.
One Question.
How Do We Turn Cells into Scalable Solutions?
03 · WHO IT'S CURATED FOR
Leaders on the path to intelligent CGT manufacturing – AI‑powered bioprocessing, agile modular capacity, human‑centred Industry 5.0 systems and sustainable, resilient operations for 2026 and beyond.
MANUFACTURING & OPERATIONS
CGTI.ai is an invite‑only deployment room for biomanufacturing, built for senior leaders across biologics, CGT and cultivated protein who are turning AI, new capacity and sustainability goals into working plants and networks in 2026.
VP Manufacturing · COO · Site Director · Head of Operations
Quality & Regulatory
VP Quality · Head of QA · Chief Quality Officer · RA Lead
It is a curated, invite‑only meeting in London for senior decision makers from biologics, cell and gene therapy and cultivated protein who sign off the next wave of capacity, technology and partnership commitments.
MSAT & PROCESS DEVELOPMENT
Head of MSAT · VP Tech Ops · Process Development Lead
Over two days the focus stays on four pillars – AI‑enabled bioprocessing, agile capacity and networks, workforce and human systems and sustainable resilient operations – because that is where 2026 decisions are actually made.
DIGITAL, DATA & R&D
VPs Innovation · VP Digital · Head of Data Science Digital Transformation Lead · Heads of R&D · Automation · Infrastructure
For technology providers and CDMOs BILS.ai is where current bioprocess and biomanufacturing trends turn into multi‑year deployment roadmaps.
For operators it is a chance to stress‑test strategies with peers who are facing the same pressures on performance, resilience and sustainability and need answers they can put into practice in their own plants.
Advisory Circle.
Advisory & Past Speakers
For the few.
leaders who sign for cost, compliance and supply
Step into the circle. Subscribe.
Stay updated. Receive the agenda. Partner with us.
